SCHEDULE: DSS Issues Convertible Note to Alset Inc., Boosting Insider Stake

DSS, Inc. issued a $500,000 convertible promissory note to Alset Inc., further solidifying the control of major shareholder Heng Fai Ambrose Chan and his affiliated entities.

Summary

• DSS, Inc. issued a $500,000 convertible promissory note to Alset Inc. on August 20, 2025.
• The convertible note allows Alset Inc. to convert outstanding principal and interest into DSS common stock at a conversion price of $0.86 per share.
• Heng Fai Ambrose Chan, through various entities including Alset Inc., Alset International Limited, and Global Biomedical Pte. Ltd., beneficially owns 6,730,059 shares, representing 69.6% of DSS's common stock.
• Alset Inc. beneficially owns 4,542,606 shares, or 47.0% of the common stock, including shares from the new convertible note.
• The total outstanding common stock of DSS, Inc. as of August 21, 2025, was 9,092,518 shares.

Sentiment

Score: 5

Explanation: The filing is neutral in terms of sentiment as it primarily reports a factual transaction and beneficial ownership update. While securing financing is positive, the potential for dilution and increased insider control could be viewed negatively by some investors.

Positives

• DSS, Inc. secured $500,000 in financing through the convertible promissory note from Alset Inc.
• The transaction demonstrates continued financial support from a major shareholder and affiliated entities.

Negatives

• The issuance of a convertible note at $0.86 per share could lead to dilution for existing minority shareholders if converted.
• The increasing concentration of ownership by Heng Fai Ambrose Chan and his affiliated entities may reduce liquidity and influence for other shareholders.

Risks

• Dilution Risk: Conversion of the promissory note into common stock at $0.86 per share will dilute the ownership percentage of existing shareholders.
• Concentrated Ownership Risk: The high percentage of beneficial ownership by Heng Fai Ambrose Chan and his affiliated entities (69.6%) could lead to decisions that primarily benefit the controlling shareholder rather than all shareholders.
• Related Party Transaction Risk: The financing is provided by a related party (Alset Inc. is controlled by Heng Fai Ambrose Chan), which may raise questions about the arm's length nature of the terms, although no specific concerns are detailed.

Future Outlook

The filing does not provide explicit forward-looking statements or guidance beyond the terms of the convertible note and its potential conversion.

Industry Context

This filing primarily concerns a change in beneficial ownership and related party financing, which does not directly provide broader industry trends. However, securing financing from a major shareholder can be a common practice for smaller or developing companies, indicating continued internal support rather than external market validation.

Related Party Transactions

• DSS, Inc. issued a $500,000 convertible promissory note to Alset Inc.
• Alset Inc. is controlled by Heng Fai Ambrose Chan, who is also a major beneficial owner of DSS, Inc.
• Heng Fai Ambrose Chan's beneficial ownership includes shares held by entities he controls (Heng Fai Holdings Limited, Alset Inc., Alset International Limited, Global Biomedical Pte. Ltd.).

Stakeholder Impact

• Shareholders: Existing minority shareholders face potential dilution upon conversion of the convertible note and increased concentration of control by the reporting persons.
• Creditors: The issuance of a convertible note adds to the company's debt, though it also provides capital.
• Company (DSS, Inc.): Receives $500,000 in capital, which can be used for operations or other corporate purposes.

Next Steps

• Alset Inc. may convert the outstanding principal and interest of the convertible note into shares of DSS common stock at $0.86 per share.

Key Dates

Recommendation

The filing indicates a capital injection through a convertible note, which provides necessary funding. However, the increasing concentration of ownership by a single beneficial owner and affiliated entities, coupled with potential dilution from the convertible note, introduces governance and liquidity concerns. Without further operational or financial performance details, a 'hold' recommendation is appropriate, advising investors to monitor future developments regarding the company's use of funds and strategic direction under this concentrated ownership.

Keywords

DSS Inc., Convertible Note, Alset Inc., Heng Fai Ambrose Chan, Schedule 13D, Beneficial Ownership, Equity Financing, Share Dilution, Corporate Governance, Related Party Transaction